Srivastava, Raghvendra M <br/><br/>
CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 2017 
 - 707-716 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-16-0879  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>4-1BB Ligand--immunology<br/>Antibodies, Monoclonal--pharmacology<br/>Antigen Presentation<br/>Antigens, Neoplasm--immunology<br/>Antineoplastic Agents, Immunological--pharmacology<br/>Carcinoma, Squamous Cell--immunology<br/>Cell Line, Tumor<br/>Cetuximab--pharmacology<br/>Cytokines--metabolism<br/>Dendritic Cells--drug effects<br/>Gene Expression Regulation, Neoplastic--genetics<br/>Genotype<br/>Head and Neck Neoplasms--immunology<br/>Humans<br/>Killer Cells, Natural--drug effects<br/>Lymphocytes--drug effects<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Polymorphism, Genetic<br/>Receptor Cross-Talk--drug effects<br/>Receptors, IgG--genetics<br/>Tumor Necrosis Factor Receptor Superfamily, Member 9--agonists<br/>Up-Regulation--drug effects